Tiphaine Parrot

Karolinska University Hospital — Sweden

Immunology and Microbiology · Life Sciences

17h-index3.4kcitations52works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(27), Immunotherapy and Immune Responses(15), Cancer Immunotherapy and Biomarkers(14), T-cell and B-cell Immunology(10), CAR-T cell therapy research(10)

Publications51 total

A validated model for early prediction of group A streptococcal aetiology in necrotising soft tissue infections using minimal patient data
BMC Medicine·2026Open Access
Additional file 1 of A validated model for early prediction of group A streptococcal aetiology in necrotising soft tissue infections using minimal patient data
Figshare·2026Open Access
A validated model for early prediction of group A streptococcal aetiology in necrotising soft tissue infections using minimal patient data
Figshare·2026Open Access
Additional file 1 of A validated model for early prediction of group A streptococcal aetiology in necrotising soft tissue infections using minimal patient data
Figshare·2026Open Access
A validated model for early prediction of group A streptococcal aetiology in necrotising soft tissue infections using minimal patient data
Figshare·2026Open Access
The HLA-B –21 M/T dimorphism associates with disease severity in COVID-19
Genes and Immunity·2024· 3 citedOpen Access
1029P Preclinical development of TCR-modified T cell therapies against mutated KRAS
Annals of Oncology·2024Open Access
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
The Journal of Infectious Diseases·2024· 5 citedOpen Access
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies
The Journal of Immunology·2023· 7 citedOpen Access
Figure S1 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Data from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Supplemental figure legends from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Figure S4 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Figure S3 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Figure S2 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Figure S1 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Figure S4 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Data from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Figure S2 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
Figure S3 from Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Johan K. Sandberg(23), Soo Aleman(21), Hans‐Gustaf Ljunggren(18), Marcus Buggert(18), Nadine Gervois(18), Niklas K. Björkström(17), Amir Khammari(17), Kristoffer Strålin(16), Olav Rooyackers(16), Brigitte Dréno(16), Nathalie Labarrière(16), Olga Rivera‐Ballesteros(15), Lars I. Eriksson(15), Jonas Klingström(15), Takuya Sekine(13), Tobias Kammann(13), Sylvain Simon(13), Virginie Vignard(13), Émilie Varey(13), Anne‐Chantal Knol(13)